(Q43040651)

12 November 2017

Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

0 references

1 reference

Naohiko Masaki

1

1 reference

12 November 2017

Sugano Fukushima

series ordinal

2

1 reference

12 November 2017

Shigeki Hayashi

series ordinal

3

1 reference

12 November 2017

1 October 2002

1 reference

Digestive Diseases and Sciences

12 November 2017

1 reference

12 November 2017

47

1 reference

12 November 2017

10

1 reference

12 November 2017

2163-2169

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1020114722763

12 November 2017

0 references

cites work

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

12 December 2020

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice

1 reference

12 December 2020

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

12 December 2020

Predictive factors in the response to interferon therapy in chronic hepatitis C.

1 reference

12 December 2020

Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection

1 reference

12 December 2020

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

1 reference

12 December 2020

In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation

1 reference

12 December 2020

CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice

1 reference

12 December 2020

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.

1 reference

12 December 2020

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

12 December 2020

Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease

1 reference

12 December 2020

Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C.

1 reference

12 December 2020

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up

1 reference

12 December 2020

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

12 December 2020

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

1 reference

12 December 2020

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

12 December 2020

Cell mediated immune response to the hepatitis C virus.

1 reference

12 December 2020

Functional diversity of helper T lymphocytes

1 reference

12 December 2020

Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification.

1 reference

12 December 2020

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

1 reference

12 December 2020

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

12 December 2020

Roles of interferon-gamma and interleukin-4 in murine lupus

1 reference

12 December 2020

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

1 reference

12 December 2020

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.

1 reference

12 December 2020

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020114722763

1 reference

Dimensions Publication ID

12 November 2017

0 references

1 reference